Why Pfizer Believes It Can Be a Leader in the GLP-1 Market, Even Though Its Drug May Not Debut Until 2028

Bản dịch chưa sẵn sàng. Đang hiển thị bài viết gốc.

Key PointsPfizer acquired a promising GLP-1 drug last year through its purchase of Metsera.